Two Sigma Investments’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-597
| Closed | -$5.46K | – | 3358 |
|
2023
Q3 | $5.46K | Sell |
597
-810
| -58% | -$7.41K | ﹤0.01% | 2835 |
|
2023
Q2 | $29.7K | Sell |
1,407
-793
| -36% | -$16.7K | ﹤0.01% | 2799 |
|
2023
Q1 | $59.2K | Sell |
2,200
-7,411
| -77% | -$199K | ﹤0.01% | 2652 |
|
2022
Q4 | $340K | Buy |
9,611
+7,924
| +470% | +$281K | ﹤0.01% | 2136 |
|
2022
Q3 | $381K | Sell |
1,687
-378
| -18% | -$85.4K | ﹤0.01% | 1846 |
|
2022
Q2 | $390K | Buy |
2,065
+1,162
| +129% | +$219K | ﹤0.01% | 1852 |
|
2022
Q1 | $225K | Buy |
+903
| New | +$225K | ﹤0.01% | 2268 |
|
2021
Q4 | – | Sell |
-901
| Closed | -$181K | – | 3255 |
|
2021
Q3 | $181K | Sell |
901
-233
| -21% | -$46.8K | ﹤0.01% | 2328 |
|
2021
Q2 | $290K | Sell |
1,134
-4,805
| -81% | -$1.23M | ﹤0.01% | 2139 |
|
2021
Q1 | $1.58M | Sell |
5,939
-2,162
| -27% | -$574K | ﹤0.01% | 1377 |
|
2020
Q4 | $2.99M | Sell |
8,101
-1,215
| -13% | -$448K | 0.01% | 917 |
|
2020
Q3 | $2.28M | Buy |
9,316
+1,899
| +26% | +$464K | 0.01% | 872 |
|
2020
Q2 | $2.14M | Buy |
7,417
+367
| +5% | +$106K | 0.01% | 849 |
|
2020
Q1 | $1.44M | Buy |
7,050
+3,735
| +113% | +$762K | 0.01% | 808 |
|
2019
Q4 | $1.48M | Buy |
3,315
+2,478
| +296% | +$1.11M | ﹤0.01% | 1232 |
|
2019
Q3 | $257K | Sell |
837
-1,744
| -68% | -$535K | ﹤0.01% | 1682 |
|
2019
Q2 | $821K | Sell |
2,581
-96
| -4% | -$30.5K | ﹤0.01% | 1426 |
|
2019
Q1 | $1.12M | Buy |
2,677
+1,322
| +98% | +$555K | ﹤0.01% | 1381 |
|
2018
Q4 | $413K | Buy |
1,355
+524
| +63% | +$160K | ﹤0.01% | 1640 |
|
2018
Q3 | $299K | Buy |
831
+44
| +6% | +$15.8K | ﹤0.01% | 1751 |
|
2018
Q2 | $288K | Buy |
+787
| New | +$288K | ﹤0.01% | 1795 |
|
2016
Q1 | – | Sell |
-188
| Closed | -$125K | – | 2423 |
|
2015
Q4 | $125K | Buy |
188
+51
| +37% | +$33.9K | ﹤0.01% | 1916 |
|
2015
Q3 | $65K | Sell |
137
-243
| -64% | -$115K | ﹤0.01% | 1574 |
|
2015
Q2 | $215K | Buy |
380
+218
| +135% | +$123K | ﹤0.01% | 2002 |
|
2015
Q1 | $1.38M | Buy |
162
+112
| +224% | +$955K | 0.01% | 1241 |
|
2014
Q4 | $442K | Buy |
+50
| New | +$442K | ﹤0.01% | 1782 |
|